Full-Time

Associate Scientist

Protein Therapeutics

Confirmed live in the last 24 hours

Gilead Sciences

Gilead Sciences

10,001+ employees

Develops and commercializes biopharmaceuticals

Compensation Overview

$109.7k - $141.9k/yr

+ Bonus + Stock-based long-term incentives

Mid, Senior

Company Historically Provides H1B Sponsorship

San Mateo, CA, USA

Category
Bioinformatics
Computational Biology
Genomics
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Strong background in protein sciences and protein biochemistry
  • Direct industry experience in purifying and characterizing a variety of recombinant proteins, particularly monoclonal antibodies and next generation biologics (e.g., bispecific antibodies, immunocytokines)
  • Hands-on experience in purification techniques including affinity, ion exchange, size exclusion, hydrophobic interaction chromatography using Akta Avant/Pure or BioRad NGC
  • Hands-on experience in protein conjugation technologies (e.g. NHS chemistry, malemide chemistry, enzymatic conjugation) and the related QC
  • Proficiency with various analytical protein characterization techniques such as SEC-HPLC or UHPLC, SDS-PAGE, Endosafe
  • Ability to perform method development and write protocols
  • Proficiency in editing and writing AKTA methods using Unicorn software
  • Detailed record-keeping is a must
  • Ability to multi-task and work in a fast-paced team environment
  • Must be team-oriented, professional, hard-working, and interested in learning new skills
  • Ability to analyze and present experimental data with proper software and other necessary tools
Responsibilities
  • Perform protein purification, conjugation, QC, and sample bank registration to support the preclinical development of biopharmaceutical programs across multiple therapeutic areas
  • Prepare technical reports, quantitative analyses, and summaries for entry into Excel, PPT, and ELN formats
  • Use good oral and written communication skills to relay scientific data
  • Actively participate in group meetings, present the results of one’s work, interpret data, and draw conclusions regarding presented material and maintain awareness of cutting-edge technical developments and scientific knowledge and apply these where possible to improve process efficiency
Desired Qualifications
  • Experience in conjugation and characterization of ADC (antibody drug conjugate) would be a plus
  • BS in Biology, Biochemistry, Chemistry with at least 6 years of relevant experience preferred
  • MS in Biology, Biochemistry, Chemistry with at least 3 years of relevant experience preferred

Gilead Sciences is a biopharmaceutical company that develops and sells medicines for various serious health conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company focuses on extensive research and development to create new therapies, which are then approved by regulatory authorities before being marketed to healthcare providers, hospitals, and pharmacies. Gilead stands out from its competitors by investing heavily in R&D and forming strategic partnerships, such as with SAP Ariba, to improve its supply chain and ensure sustainable practices. The company's goal is to enhance health equity and access to care, working with communities globally to remove barriers to healthcare and make its medicines available to those in need.

Company Size

10,001+

Company Stage

IPO

Headquarters

Foster City, California

Founded

1987

Simplify Jobs

Simplify's Take

What believers are saying

  • Gilead's $32 billion U.S. investment will create over 3,000 jobs by 2028.
  • The reformulation of lenacapavir offers long-acting HIV prevention, improving patient adherence.
  • Gilead's top five ranking in the Most JUST list highlights its corporate responsibility.

What critics are saying

  • A $202 million settlement for legal violations may damage Gilead's reputation.
  • Layoffs of 150 employees, including senior management, could disrupt company operations.
  • AI-driven drug discovery companies pose a competitive threat to Gilead's traditional R&D.

What makes Gilead Sciences unique

  • Gilead focuses on innovative medicines for unmet needs like HIV/AIDS and liver diseases.
  • The company invests heavily in R&D to maintain a robust pipeline of new treatments.
  • Gilead's partnerships enhance product offerings and expand market reach globally.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Company News

Fierce Pharma
May 8th, 2025
Gilead tees up $11B in new US manufacturing, R&D investments

This time it's Gilead coming to the table with a fresh $11 billion in hand to spend across its manufacturing and research centers in the U.S.

Gilead Sciences
May 7th, 2025
Gilead U.S. Investment to Create $43 Billion in Value to U.S. Economy

Gilead to invest $32 billion in U.S. manufacturing and R&D through 2030 and create more than 3,000 direct and indirect jobs by 2028

Constantine Cannon
May 5th, 2025
Gilead Pays $202M to Settle False Claims Act Kickback Charges

On April 29, the Department of Justice (DOJ) announced that California-based pharmaceutical giant Gilead Sciences agreed to pay $202 million to settle charges of violating the False Claims Act and Anti-Kickback Statute.

Financial Modeling Prep
May 2nd, 2025
Amgen Inc. (NASDAQ:AMGN) Surpasses Earnings and Sales Estimates in Q1 2025

Amgen competes with other biotech giants like Gilead Sciences and Biogen.

SFist
Apr 2nd, 2025
April Fool's Day Around the Bay: Bob Lee's Family Has Sued His Convicted Killer Nima Momeni

Foster City-based HIV drug company Gilead Sciences is laying off nearly 150 people, and the job cuts are significant among senior members of the company's management.